Cargando…

Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease

BACKGROUND: The role of aspirin in primary cardiovascular disease prevention in patients with diabetes remains controversial. However, some studies have suggested beneficial effects of cilostazol on cardiovascular disease in patients with diabetes. We prospectively investigated the antiplatelet effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Sangmo, Lee, Woo Je, Park, Cheol-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081299/ https://www.ncbi.nlm.nih.gov/pubmed/35381686 http://dx.doi.org/10.3803/EnM.2021.1353

Ejemplares similares

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Effects of aspirin combined with cilostazol on thromboangiitis obliterans in diabetic patients
por: Yong, Jun, et al.
Publicado: (2018)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Hemorrhagic Cholecystitis in an Elderly Patient Taking Aspirin and Cilostazol
por: Morris, David S., et al.
Publicado: (2008)

Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro
por: Kwon, Hyuk-Woo, et al.
Publicado: (2016)

Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study
por: Seo, Woo‐Keun, et al.
Publicado: (2021)

Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database
por: Noh, Yoojin, et al.
Publicado: (2016)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Cilostazol combined with P2Y(12) receptor inhibitors: A substitute antiplatelet regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation
por: Zhao, Yikai, et al.
Publicado: (2022)

Effect of Cilostazol on the Neuropathies of Streptozotocin-Induced Diabetic Rats
por: Suh, Kwang Sik, et al.
Publicado: (1999)

Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
por: Yamasaki, Yoshimitsu, et al.
Publicado: (2006)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model
por: Tara, Shuhei, et al.
Publicado: (2015)

Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
por: Byun, Sungwook, et al.
Publicado: (2022)

Effectiveness of cilostazol in transient ischemic attack refractory to aspirin: A report of two cases
por: LIN, GAOPING, et al.
Publicado: (2014)

Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke
por: Zhou, Lily W., et al.
Publicado: (2022)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
por: Uchiyama, Shinichiro, et al.
Publicado: (2015)

Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
por: Konosic, Sanja, et al.
Publicado: (2019)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Study
por: Kim, Kyung-Soo, et al.
Publicado: (2022)

Antiplatelet Effectivity between Aspirin with Honey on Cardiovascular Disease Based on Bleeding Time Taken on Mice
por: Martina, Sake Juli, et al.
Publicado: (2019)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study
por: Kimura, Teruo, et al.
Publicado: (2016)

The Efficacy and Safety of Cilostazol vs. Aspirin for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis
por: Chai, Erqing, et al.
Publicado: (2022)

The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study
por: Hong, Sangmo, et al.
Publicado: (2020)

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2017)

Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
por: Sawardekar, Swapna B., et al.
Publicado: (2016)

Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot Study
por: Ohnuki, Yoichi, et al.
Publicado: (2017)

Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset
por: Aoki, Junya, et al.
Publicado: (2019)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease
por: Cha, Jung‐Joon, et al.
Publicado: (2023)

A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial
por: Han, Hyun Jeong, et al.
Publicado: (2019)

Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia
por: Lima, Paulo Roberto da Silva, et al.
Publicado: (2016)

Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH
por: Park, Joon Beom, et al.
Publicado: (2023)

Neurite Outgrowth Mediated by Translation Elongation Factor eEF1A1: A Target for Antiplatelet Agent Cilostazol
por: Hashimoto, Kenji, et al.
Publicado: (2011)

Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial
por: Toyoda, Kazunori, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7sfsmctd1p7hf1udmosm2kpl0i